Factory Mutual Insurance Co. Raises Holdings in Corteva, Inc. $CTVA

Factory Mutual Insurance Co. boosted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 1.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 671,058 shares of the company’s stock after acquiring an additional 8,000 shares during the quarter. Factory Mutual Insurance Co. owned 0.10% of Corteva worth $45,384,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. NORTHSTAR ASSET MANAGEMENT Co increased its holdings in shares of Corteva by 2.2% during the 2nd quarter. NORTHSTAR ASSET MANAGEMENT Co now owns 6,940 shares of the company’s stock valued at $517,000 after purchasing an additional 150 shares in the last quarter. Empirical Finance LLC grew its position in Corteva by 0.6% during the second quarter. Empirical Finance LLC now owns 24,935 shares of the company’s stock valued at $1,858,000 after buying an additional 153 shares during the period. Carnegie Investment Counsel increased its holdings in Corteva by 3.0% in the second quarter. Carnegie Investment Counsel now owns 5,607 shares of the company’s stock valued at $418,000 after buying an additional 164 shares in the last quarter. United Community Bank raised its position in shares of Corteva by 10.5% in the third quarter. United Community Bank now owns 1,849 shares of the company’s stock worth $125,000 after acquiring an additional 176 shares during the period. Finally, Curat Global LLC raised its position in shares of Corteva by 93.7% in the second quarter. Curat Global LLC now owns 370 shares of the company’s stock worth $28,000 after acquiring an additional 179 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Stock Up 0.5%

Shares of CTVA opened at $77.00 on Friday. The stock has a 50 day moving average price of $70.51 and a 200 day moving average price of $68.57. Corteva, Inc. has a one year low of $53.40 and a one year high of $77.41. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The stock has a market capitalization of $51.78 billion, a price-to-earnings ratio of 48.74, a PEG ratio of 2.61 and a beta of 0.75.

Corteva (NYSE:CTVA) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. During the same quarter in the previous year, the company posted $0.32 EPS. The firm’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities research analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Analyst Ratings Changes

CTVA has been the topic of a number of analyst reports. CICC Research raised their target price on Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research report on Wednesday, February 11th. Wolfe Research raised their price objective on Corteva from $81.00 to $86.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Mizuho boosted their price objective on Corteva from $80.00 to $82.00 and gave the company an “outperform” rating in a research report on Tuesday. Royal Bank Of Canada increased their target price on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. Finally, Rothschild & Co Redburn dropped their price target on shares of Corteva from $71.00 to $65.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 11th. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Corteva presently has a consensus rating of “Moderate Buy” and an average price target of $82.30.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.